SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950123-09-019984
Filing Date
2009-07-02
Accepted
2009-07-02 16:09:02
Documents
2
Group Members
ARGERIS KARABELASCDC IV, LLCCDC OPERATIONS LLCDAVID R. RAMSAYJAN LESCHLY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A c87575sc13dza.htm SC 13D/A 83663
2 EXHIBIT 99.Q c87575exv99wq.htm EX-99.Q 31572
  Complete submission text file 0000950123-09-019984.txt   117437
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Subject) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-57907 | Film No.: 09927541
SIC: 2834 Pharmaceutical Preparations

Mailing Address 47 HULFISH STREET SUITE 310 PRINCETON NJ 08542
Business Address 47 HULFISH STREET SUITE 310 PRINCETON NJ 08542 609-683-8300
CDC IV LLC (Filed by) CIK: 0001365385 (see all company filings)

IRS No.: 204153867 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A